
The first MSc thesis developed within Fetalix, by Leonor Sousa, titled “Fetalix in vivo validation and process scalability,” has recently been completed and defended.

Fetalix has launched a new visual identity developed in collaboration with Vogal, a creative studio led by Ana Pessanha, Paulo Sá, Daniel Teixeira, and Lucas Aranha. The rebranding reflects the company’s evolution in regenerative medicine and its continued development as a biotechnology startup.

Fetalix has joined Startup Braga’s incubation programme, becoming part of a dynamic innovation ecosystem that supports the growth and development of technology-driven startups. The incubation provides Fetalix with access to a collaborative environment, specialised resources, and a network of entrepreneurs, mentors, and industry experts, supporting the company’s journey as it advances its innovative solutions in the health sector.